COGENT BIOSCIENCES INC (COGT)

US19240Q2012 - Common Stock

6.71  +0.1 (+1.51%)

After market: 6.71 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.007.87M22.50M
Operating Expenses
208.13M147.84M75.55M90.07M54.68M
Research and Development
173.75M121.63M55.91M72.65M43.71M
Selling, General, and Administrative Expenses
34.38M26.21M19.64M17.42M10.97M
Operating Income
-208.13M-147.84M-75.55M-82.20M-32.18M
Interest Income/Expense
13.08M3.99M470.00K140.00K270.00K
Other Income/Expense
2.64M4.01M2.81M-250.00K80.00K
Non Recurring Items
N/A-400.00KN/AN/AN/A
Income Before Taxes
-192.41M-140.24M-72.27M-74.81M-31.83M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-192.41M-140.24M-72.27M-179.21M-31.83M
EBITDA
-205.86M-147.00M-75.40M-81.48M-30.89M
 
Per Share Data
EPS Diluted Total Ops
-2.42-2.39-1.87-16.17-4.18
Non GAAP EPS
-2.40-2.45-1.85-8.10-4.20
 
Statistics
Profit Margin
N/AN/AN/A-2277.13%-141.47%
Operating Profit Margin
N/AN/AN/A-1044.47%-143.02%

All data in USD

Charts